# FDA Inspection 1200692 - BioLife Plasma Services, L.P. - March 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/0c379bc2-8d56-4e0b-9a8e-6ad6e46e3fd8
Source feed: FDA_Inspections

> FDA Inspection 1200692 for BioLife Plasma Services, L.P. on March 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200692
- Company Name: BioLife Plasma Services, L.P.
- Inspection Date: 2023-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1200692 - 2023-03-14](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/b9c5ada2-f05d-4f6d-9593-9d78091bfc44)
- [FDA Inspection 1028514 - 2017-09-20](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/131d6b18-eff6-4899-9b34-affa37d21213)

Company: https://www.keypedia.com/companies/biolife-plasma-services-lp/a269256a-bb69-4024-b8b8-ff940b4a61b2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d